Fayez Sarofim & Co

Position in LLY — ELI LILLY & Co

CIK 937729 Houston, TX

Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$510,582,998

+$121,361,170 QoQ

Shares Held

425,688

+0.6% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

1.20%

of 13F equity value

Holder Rank

#143

of 4,605 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 8% Shared 0% None 92%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Fayez Sarofim & Co holds $1,793,961,393 across 10 Drug Manufacturers - General names. LLY ranks #2 (28.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	2,876,785	$723,914,175
2	LLY	ELI LILLY & Co This page	425,688	$510,582,998
3	MRK	Merck & Co., Inc.	1,664,909	$213,940,806
4	JNJ	Johnson & Johnson	688,542	$174,869,011
5	NVO	Novo Nordisk A S	2,924,500	$140,200,529
6	AMGN	Amgen Inc	54,394	$19,697,155
7	PFE	Pfizer Inc	233,339	$5,618,802
8	NVS	Novartis AG	28,162	$4,413,548

All Filings in LLY

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$510,582,998	425,688	+0.6%	Shares	Defined	2026-08-17
2026-03-31	$389,221,828	423,173	-0.3%	Shares	Defined	2026-05-15
2025-12-31	$456,089,933	424,396	-2.7%	Shares	Defined	2026-02-13
2025-09-30	$332,791,606	436,162	+2.5%	Shares	Defined	2025-11-14
2025-06-30	$331,799,148	425,640	-4.0%	Shares	Defined	2025-08-14
2025-03-31	$366,362,937	443,587	+12.2%	Shares	Defined	2025-05-12
2024-12-31	$305,169,284	395,297	+7.5%	Shares	Defined	2025-02-14
2024-09-30	$325,915,177	367,875	+10.9%	Shares	Defined	2024-11-14
2024-06-30	$300,349,854	331,739	+8.2%	Shares	Defined	2024-08-14
2024-03-31	$238,420,623	306,469	+0.4%	Shares	Defined	2024-05-14
2023-12-31	$178,022,018	305,397	+13.5%	Shares	Defined	2024-02-15
2023-09-30	$144,571,224	269,155	+15.4%	Shares	Defined	2023-11-15
2023-06-30	$109,360,038	233,187	+17.0%	Shares	Defined	2023-08-14
2023-03-31	$68,436,050	199,278	+37.5%	Shares	Defined	2023-05-11
2022-12-31	$53,029,239	144,952	+320.3%	Shares	Defined	2023-02-13
2022-09-30	$11,150,724	34,485	+1.2%	Shares	Defined	2022-11-15
2022-06-30	$11,043,273	34,060	+3.6%	Shares	Defined	2022-08-12
2022-03-31	$9,412,981	32,870	+3.6%	Shares	Defined	2022-05-16
2021-12-31	$8,762,250	31,722	+7.8%	Shares	Defined	2022-02-11
2021-09-30	$6,797,722	29,421	-0.5%	Shares	Defined	2021-11-15
2021-06-30	$6,788,512	29,577	+6.8%	Shares	Defined	2021-08-13
2021-03-31	$5,171,737	27,683	-13.1%	Shares	Defined	2021-05-13
2020-12-31	$5,378,735	31,857	-2.3%	Shares	Defined	2021-02-11
2020-09-30	$4,828,708	32,622	+26.0%	Shares	Defined	2020-11-13
2020-06-30	$4,250,947	25,892	-35.8%	Shares	Defined	2020-08-11
2020-03-31	$5,598,461	40,358	—	Shares	Defined	2020-05-12
No filing history on record for this holder in this stock.